Listed

Veradermics, Inc

MANENYSECIK 1827635HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$29.6m, Q2 FY2026
Net income−$23.5m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m11.4Research and development, period not labelled, three months to 2025-03-31$11.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure14.3Research and development, period not labelled, three months to 2025-06-30$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure20.9Research and development, Q1 FY2026, three months to 2026-03-31$20.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure18.6Research and development, Q2 FY2026, three months to 2026-06-30$18.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Operating income$m(12.9)Operating income, period not labelled, three months to 2025-03-31−$12.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure(16.1)Operating income, period not labelled, three months to 2025-06-30−$16.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure(29.9)Operating income, Q1 FY2026, three months to 2026-03-31−$29.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure(29.6)Operating income, Q2 FY2026, three months to 2026-06-30−$29.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Income tax$m0.0Income tax, period not labelled, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure0.0Income tax, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Net income$m(12.4)Net income, period not labelled, three months to 2025-03-31−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure(15.6)Net income, period not labelled, three months to 2025-06-30−$15.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure(27.2)Net income, Q1 FY2026, three months to 2026-03-31−$27.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure(23.5)Net income, Q2 FY2026, three months to 2026-06-30−$23.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Diluted EPS$ per share(19.79)Diluted EPS, period not labelled, three months to 2025-03-31−$19.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure(24.19)Diluted EPS, period not labelled, three months to 2025-06-30−$24.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure(1.32)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure(0.58)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Basic EPS$ per share(19.79)Basic EPS, period not labelled, three months to 2025-03-31−$19.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure(24.19)Basic EPS, period not labelled, three months to 2025-06-30−$24.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure(1.32)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure(0.58)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure

Balance sheet

Cash and equivalents$319.3m, Q2 FY2026
Shareholders' equity$813.6m, Q2 FY2026
Line itemUnitperiod not labelled2023-12-31period not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported53.1Cash and equivalents, period not labelled, at 2024-12-31$53.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001827635-26-000013.Report this figurenot reportednot reported21.8Cash and equivalents, FY2025, at 2025-12-31$21.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure168Cash and equivalents, Q1 FY2026, at 2026-03-31$168.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure319Cash and equivalents, Q2 FY2026, at 2026-06-30$319.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Current assets$mnot reported55.5Current assets, period not labelled, at 2024-12-31$55.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001827635-26-000013.Report this figurenot reportednot reported152Current assets, FY2025, at 2025-12-31$152.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure397Current assets, Q1 FY2026, at 2026-03-31$397.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure825Current assets, Q2 FY2026, at 2026-06-30$824.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Total assets$mnot reported55.5Total assets, period not labelled, at 2024-12-31$55.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001827635-26-000013.Report this figurenot reportednot reported153Total assets, FY2025, at 2025-12-31$152.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure397Total assets, Q1 FY2026, at 2026-03-31$397.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure826Total assets, Q2 FY2026, at 2026-06-30$825.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Current liabilities$mnot reported4.7Current liabilities, period not labelled, at 2024-12-31$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001827635-26-000013.Report this figurenot reportednot reported9.2Current liabilities, FY2025, at 2025-12-31$9.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure6.7Current liabilities, Q1 FY2026, at 2026-03-31$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure11.7Current liabilities, Q2 FY2026, at 2026-06-30$11.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Total liabilities$mnot reported4.7Total liabilities, period not labelled, at 2024-12-31$4.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001827635-26-000013.Report this figurenot reportednot reported9.2Total liabilities, FY2025, at 2025-12-31$9.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure6.7Total liabilities, Q1 FY2026, at 2026-03-31$6.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure12.1Total liabilities, Q2 FY2026, at 2026-06-30$12.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure
Shareholders' equity$m(22.2)Shareholders' equity, period not labelled, at 2023-12-31−$22.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001827635-26-000013.Report this figure(48.5)Shareholders' equity, period not labelled, at 2024-12-31−$48.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure(60.7)Shareholders' equity, period not labelled, at 2025-03-31−$60.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure(76.1)Shareholders' equity, period not labelled, at 2025-06-30−$76.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure(121)Shareholders' equity, FY2025, at 2025-12-31−$121.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure391Shareholders' equity, Q1 FY2026, at 2026-03-31$390.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure814Shareholders' equity, Q2 FY2026, at 2026-06-30$813.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure

Cash flow

Operating cash flow−$14.5m, Q2 FY2026
Capital expenditure$21.0k, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(13.3)Operating cash flow, period not labelled, three months to 2025-03-31−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure(15.6)Operating cash flow, period not labelled, three months to 2025-06-30−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001827635-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure(21.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$21.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure(14.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001827635-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, period not labelled, three months to 2025-03-31$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure0.0Capital expenditure, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001827635-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001827635-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)40.44m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.7Diluted shares (weighted), period not labelled, three months to 2025-03-31736,933 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure0.7Diluted shares (weighted), period not labelled, three months to 2025-06-30744,641 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure22.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3122,704,124 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001827635-26-000019.Report this figure40.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3040,436,264 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure

Shares outstanding: 41.78mShares outstanding, period not labelled, at 2026-08-0641,780,136 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001827635-26-000030.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.